CoreWeave's acquisition of Core Scientific aims to enhance AI and HPC capabilities, although market reactions reflect concerns over stock volatility.
CoreWeave has announced the acquisition of Core Scientific in an all-stock transaction valued at approximately $9 billion. Following the announcement, Core Scientific's stock fell 17%, indicating market disappointment over the deal structure. Analysts express concerns about potential stock volatility before the deal's expected completion in Q4.